Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…
The post New patent expiration for APGDI drug MYRBETRIQ appeared first on DrugPatentWatch - Make Better Decisions.